Genfit is a biopharmaceutical company based in France that focuses on metabolic and liver diseases. It develops small-molecule drug candidates that act on nuclear receptors and related biological pathways, with its main programmes aimed at cholestatic and other chronic liver conditions. The company also works on diagnostic approaches for liver disease, often in partnership with other firms. Its customers and collaborators are mainly healthcare professionals, hospitals and pharmaceutical partners involved in treating patients with liver disorders.
On this site Genfit S.A. appears as a stock on the Euronext Paris (France), code GNFT, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #264 of 625 on the Euronext Paris · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for France yet.
TrendFair
57/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-11.9%
From 52-week high-40.9%
MomentumFair
63/100
Typical recent returns for this exchange.
See the numbers →
3-month return-35.0%
6-month return5.7%
12-month, skipping last month176.1%
Stability (higher is calmer)Weak
31/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)60.1%
Worst drawdown, 1 year (smaller is calmer)-46.6%
LiquidityStrong
87/100
Trades actively.
See the numbers →
Avg daily value traded3.79M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for France when fundamentals data for this market is added. All France stocks.
52-wk range 3.400 – 15.480Daily closes, split-adjusted
Signals
50-day average11.271
200-day average9.837
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.590
Technical summary
Daily
Strongly bearish
1 bullish · 4 neutral · 11 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
8.48
Bullish
EMA 10
8.73
Bearish
SMA 20
8.84
Bearish
EMA 20
9.11
Bearish
SMA 50
11.27
Bearish
EMA 50
10.38
Bearish
SMA 100
11.71
Bearish
EMA 100
10.70
Bearish
SMA 200
9.84
Bearish
EMA 200
9.70
Bearish
Oscillators (daily)
RSI (14)
40.91
Neutral
MACD (12, 26)
-0.67
Bearish
Momentum (12)
-4.93
Bearish
Stochastic %K (14)
50.00
Neutral
Williams %R (14)
-50.00
Neutral
CCI (20)
-20.45
Neutral
Pivot points (classic, last session)
S3
7.99
S2
8.23
S1
8.45
Pivot
8.69
R1
8.91
R2
9.15
R3
9.37
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
